World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
22420
World Ranking
15250
National Ranking
582

Overview

Ron H.J. Mathijssen is affiliated with Erasmus University Rotterdam in the Netherlands. Their research primarily focuses on medicine, with a substantial body of work in oncology, pulmonary and respiratory medicine, molecular biology, genetics, and cancer research.

The scientist's recent published papers include:

  • Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and Differences, 2020, Drugs
  • Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients, 2021, Circulation Research
  • Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients, 2020, Cancer Immunology Immunotherapy
  • Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in Cancer Patients, 2020, Thyroid
  • Cross-resistance and drug sequence in prostate cancer, 2021, Drug Resistance Updates

Their frequent co-authors include:

  • Stijn L.W. Koolen (125 publications)
  • Esther Oomen-de Hoop (72 publications)
  • Anne-Marie C. Dingemans (42 publications)
  • Peter de Bruijn (39 publications)
  • Ron H. N. van Schaik (37 publications)

Publications are commonly found in the following venues:

  • Annals of Oncology (43 publications)
  • Biomedicine & Pharmacotherapy (17 publications)
  • European Journal of Cancer (13 publications)
  • Clinical Pharmacology & Therapeutics (10 publications)
  • Clinical Pharmacokinetics (10 publications)

The main fields of study encompass medicine, with focused areas in:

  • Oncology (196 publications)
  • Pulmonary and Respiratory Medicine (147 publications)
  • Molecular Biology (55 publications)
  • Genetics (45 publications)
  • Cancer Research (38 publications)

The primary research topics covered include:

  • Lung Cancer Treatments and Mutations (102 publications)
  • Cancer Immunotherapy and Biomarkers (62 publications)
  • Colorectal Cancer Treatments and Studies (62 publications)
  • Cancer Treatment and Pharmacology (62 publications)
  • Estrogen and related hormone effects (46 publications)
  • Gastric Cancer Management and Outcomes (42 publications)
  • Cancer Genomics and Diagnostics (40 publications)

Best Publications

  • Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)

    Ron H. J. Mathijssen;Robbert J. van Alphen;Jaap Verweij;Walter J. Loos

  • Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial

    Amit M Oza;David Cibula;Ana Oaknin Benzaquen;Christopher Poole

  • Effects of St. John's Wort on Irinotecan Metabolism

    Ron H. J. Mathijssen;Jaap Verweij;Peter de Bruijn;Walter J. Loos

  • Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity.

    Kelly K. Filipski;Kelly K. Filipski;Ron H. Mathijssen;Torben S. Mikkelsen;Torben S. Mikkelsen;Alfred H. Schinkel

  • Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics

    Femke M. de Man;Andrew K. L. Goey;Ron H. N. van Schaik;Ron H. J. Mathijssen

  • DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.

    Linda M. Henricks;Carin A.T.C. Lunenburg;Femke M. de Man;Didier Meulendijks

  • Irinotecan Pathway Genotype Analysis to Predict Pharmacokinetics

    Ron H. J. Mathijssen;Sharon Marsh;Mats O. Karlsson;Rujia Xie

  • Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspective

    Roelof W F van Leeuwen;Teun van Gelder;Ron H J Mathijssen;Frank G A Jansman

  • Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs

    van Robert Leeuwen;van Robert Leeuwen;D. H. S. Brundel;C. Neef;T. van Gelder

  • Drug transporters of platinum-based anticancer agents and their clinical significance

    Herman Burger;Walter J. Loos;Karel Eechoute;Jaap Verweij

  • Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and Differences

    C. Louwrens Braal;Elisabeth M. Jongbloed;Saskia M. Wilting;Ron H. J. Mathijssen

  • ABCG2 Pharmacogenetics: Ethnic Differences in Allele Frequency and Assessment of Influence on Irinotecan Disposition

    Floris A. de Jong;Sharon Marsh;Ron H. J. Mathijssen;Cristi King

  • Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells

    Wendy Onstenk;Anieta M. Sieuwerts;Jaco Kraan;Mai Van

  • miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.

    M T M van Jaarsveld;J Helleman;A W M Boersma;P F van Kuijk

  • Pharmacogenetic Pathway Analysis for Determination of Sunitinib-Induced Toxicity

    Nielka P. van Erp;Karel Eechoute;Astrid A. van der Veldt;John B. Haanen

  • Complementary and Alternative Medicine During Cancer Treatment: Beyond Innocence

    Metin Tascilar;Floris A. de Jong;Jaap Verweij;Ron H. J. Mathijssen

  • Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancer

    R.J. van Soest;M.E. van Royen;E.S. de Morrée;J.M. Moll

  • Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein.

    Fa de Jong;TJ Scott-Horton;DL Kroetz;HL McLeod

  • Drug transporters and imatinib treatment: Implications for clinical practice

    Karel Eechoute;Alex Sparreboom;Herman Burger;Ryan M. Franke

  • Evaluation of Alternate Size Descriptors for Dose Calculation of Anticancer Drugs in the Obese

    Alex Sparreboom;Antonio C. Wolff;Ron H.J. Mathijssen;Etienne Chatelut

Frequent Co-Authors

Jaap Verweij
Jaap Verweij Erasmus University Rotterdam
Alex Sparreboom
Alex Sparreboom The Ohio State University
Stefan Sleijfer
Stefan Sleijfer Erasmus University Rotterdam
Ron H.N. van Schaik
Ron H.N. van Schaik Erasmus University Rotterdam
Hans Gelderblom
Hans Gelderblom Leiden University Medical Center
Jos H. Beijnen
Jos H. Beijnen Utrecht University
Jan H.M. Schellens
Jan H.M. Schellens Utrecht University
Henk-Jan Guchelaar
Henk-Jan Guchelaar Leiden University Medical Center
Teun van Gelder
Teun van Gelder Leiden University Medical Center
Sharyn D. Baker
Sharyn D. Baker The Ohio State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine but want flexible options, online nursing degrees offer valuable alternatives. For registered nurses wanting to advance without extensive in-person requirements, online rn to bsn programs no clinicals provide an efficient path to earning a BSN entirely online. This can be ideal for working professionals seeking advancement.

Looking to reach the highest levels in nursing? There are several dnp online programs designed for those pursuing a Doctor of Nursing Practice. Students needing to complete their doctorate on a tight schedule may benefit from accelerated dnp programs online, which significantly reduce time-to-degree for qualified applicants.

For those just starting their nursing journey, online lpn programs offer fast, flexible study options to become a Licensed Practical Nurse. These credentials lay the groundwork for entry into the medical workforce, with opportunities to continue education later. Exploring these online pathways can help you find the right fit for your goals in healthcare.

Best Scientists Citing Ron H.J. Mathijssen

Trending Scientists

Recently Published Articles